Unique Clinically Relevant Prognostic Indicators After TIPS Placement in Cirrhosis Patients with Pre-Existing Kidney Disease

<b>Background</b>: Transjugular intrahepatic portosystemic shunt (TIPSS) outcomes in patients with moderate-to-severe pre-existing kidney disease (PKD, stages G3a-G4) remain poorly characterized. This study aimed to identify potential predictors of mortality specifically in patients with an eGFR 15-59 mL/min/1.73 m<sup>2</sup>. <b>Methods</b>: We retrospectively analyzed 68 cirrhosis patients with PKD (eGFR < 60 mL/min/1.73 m<sup>2</sup>) undergoing a TIPSS between April 2021 and April 2024. Clinical outcomes, renal function changes, and 12-month survival were assessed. Statistical analyses included paired <i>t</i>-tests with false discovery rate adjustment and Kaplan-Meier survival analysis to identify potential predictors of mortality. <b>Results</b>: The cohort (mean age 61.0 ± 8.3 years, 83.8% male, 79.4% with PKD G3a-G3b) showed modest improvement in renal function (creatinine 1.93 to 1.75 mg/dL, <i>p</i> = 0.031), though this biochemical change did not predict survival. Overall mortality was 36.8% (95% CI: 25.4-49.5%) at mean follow-up of 6.7 months. Traditional severity scores (MELD, Child-Turcotte-Pugh) showed no significant association with survival (<i>p</i> > 0.05 for all comparisons). In exploratory analyses, mortality was significantly higher in patients with the following: (1) uncontrolled diabetes before a TIPSS (55.2% vs. 25.9%; RR 2.35, 95% CI: 1.08-5.15, <i>p</i> = 0.032); (2) post-TIPSS infection (70.0% vs. 31.0%; HR 5.44, 95% CI: 1.54-19.23, <i>p</i> = 0.009); and (3) post-procedural cardiac events (85.7% vs. 31.1%; <i>p</i> = 0.005). These associations persisted after false-discovery rate adjustment but require prospective validation given the modest sample size and wide confidence intervals. <b>Conclusions</b>: In this exploratory single-center study of patients with moderate PKD undergoing a TIPSS, we observed associations between mortality and pre-TIPSS poorly controlled diabetes, infections, and cardiac events. These hypothesis-generating findings suggest potential areas for future research. Prospective multi-center studies are needed to validate these associations and determine whether interventions targeting these factors improve outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-01-06
DOI
https://doi.org/10.3390/jcm15020414
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unique Clinically Relevant Prognostic Indicators After TIPS Placement in Cirrhosis Patients with Pre-Existing Kidney Disease

Ajit K. Tharakan, Tharun Tom Oommen, A. Grace Baby, Arif Hussain Theruvath et al.
Journal of Clinical Medicine
Liver Disease and Transplantation
article

Unique Clinically Relevant Prognostic Indicators After TIPS Placement in Cirrhosis Patients with Pre-Existing Kidney Disease

Ajit K. Tharakan, Tharun Tom Oommen, A. Grace Baby, Arif Hussain Theruvath, Philip Augustine, Cyriac Abby Philips, Rajesh K Sasidharan, Aryalakshmi Sreemohan, Rizwan Ahamed
article en

Abstract

<b>Background</b>: Transjugular intrahepatic portosystemic shunt (TIPSS) outcomes in patients with moderate-to-severe pre-existing kidney disease (PKD, stages G3a-G4) remain poorly characterized. This study aimed to identify potential predictors of mortality specifically in patients with an eGFR 15-59 mL/min/1.73 m<sup>2</sup>. <b>Methods</b>: We retrospectively analyzed 68 cirrhosis patients with PKD (eGFR < 60 mL/min/1.73 m<sup>2</sup>) undergoing a TIPSS between April 2021 and April 2024. Clinical outcomes, renal function changes, and 12-month survival were assessed. Statistical analyses included paired <i>t</i>-tests with false discovery rate adjustment and Kaplan-Meier survival analysis to identify potential predictors of mortality. <b>Results</b>: The cohort (mean age 61.0 ± 8.3 years, 83.8% male, 79.4% with PKD G3a-G3b) showed modest improvement in renal function (creatinine 1.93 to 1.75 mg/dL, <i>p</i> = 0.031), though this biochemical change did not predict survival. Overall mortality was 36.8% (95% CI: 25.4-49.5%) at mean follow-up of 6.7 months. Traditional severity scores (MELD, Child-Turcotte-Pugh) showed no significant association with survival (<i>p</i> > 0.05 for all comparisons). In exploratory analyses, mortality was significantly higher in patients with the following: (1) uncontrolled diabetes before a TIPSS (55.2% vs. 25.9%; RR 2.35, 95% CI: 1.08-5.15, <i>p</i> = 0.032); (2) post-TIPSS infection (70.0% vs. 31.0%; HR 5.44, 95% CI: 1.54-19.23, <i>p</i> = 0.009); and (3) post-procedural cardiac events (85.7% vs. 31.1%; <i>p</i> = 0.005). These associations persisted after false-discovery rate adjustment but require prospective validation given the modest sample size and wide confidence intervals. <b>Conclusions</b>: In this exploratory single-center study of patients with moderate PKD undergoing a TIPSS, we observed associations between mortality and pre-TIPSS poorly controlled diabetes, infections, and cardiac events. These hypothesis-generating findings suggest potential areas for future research. Prospective multi-center studies are needed to validate these associations and determine whether interventions targeting these factors improve outcomes.

Journal of Clinical MedicineVol. 15(2)
Rajagiri Hospital (IN)
Good health and well-being
Openalex Percentile: Top 97%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.